drugset / Trial / NCT06618079
Drug-Drug Interaction Study Between HUC2-565-A and HUC2-565-B
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate a pharmacokinetic drug interaction and safety.
Timeline
- Start
- 2024-04-20
- Primary completion
- 2024-07-12
- Completion
- 2024-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HUC2-565-A | Unknown | — | — |
| Subject | HUC2-565-B | Unknown | — | — |